Author:
Nafar Mohsen,Samavat Shiva
Reference82 articles.
1. Abou-Ragheb HH, Williams AJ, Brown CB, et al. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis. Nephron. 1992;62:22–6.
2. Bazzi C, Rizza V, Raimondi S, et al. In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression. Clin J Am Soc Nephrol. 2009a;4:929–35.
3. Bazzi C, Rizza V, Paparella M, et al. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy. J Nephrol. 2009b;22:387–96.
4. Boyd JK, Barratt J. Immune complex formation in IgA nephropathy: CD89 a ‘saint’ or a ‘sinner’? Kidney Int. 2010;78:1211–3.
5. Boyd JK, Cheung CK, Molyneux K, et al. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int. 2012;81:833–43.